Promega

Caspase-Glo® 3/7 Assay System

#G810C

5
Citing papers
70
Combined citations
Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations3PI3K/AKT/mTOR signaling in cancer2Tryptophan and brain disorders2Cancer-related Molecular Pathways1Chronic Lymphocytic Leukemia Research1Adipose Tissue and Metabolism1Endoplasmic Reticulum Stress and Disease1Mitochondrial Function and Pathology1

Papers citing this product

1
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib
npj Precision Oncology·2021·49 cit.·DOI
2
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors
Molecular Cancer Therapeutics·2023·14 cit.·DOI
3
Aripiprazole, but Not Olanzapine, Alters the Response to Oxidative Stress in Fao Cells by Reducing the Activation of Mitogen-Activated Protein Kinases (MAPKs) and Promoting Cell Survival
International Journal of Molecular Sciences·2024·5 cit.·DOI
4
Aripiprazole, but Not Olanzapine, Alters the Response to Oxida-Tive Stress, Reducing the Activation of Mitogen-Activated Protein Kinases (MAPKs) and Promoting Cell Survival in FAO Cells
Preprints.org·2024·1 cit.·DOI
5
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy
RSC Medicinal Chemistry·2025·1 cit.·DOI

Similar products

ProductVendorPricePapers
Caspase-Glo® 3/7 Assay SystemPromega—100
Caspase-Glo® 3/7 Assay SystemPromega—100
Caspase-Glo® 3/7 Assay SystemPromega—42
Caspase-Glo® 3/7 Assay SystemPromega—5
Caspase-Glo® 3/7 Assay SystemPromega—4
Caspase-Glo® 3/7 Assay SystemPromega—3
Caspase-Glo® 3/7 Assay SystemPromega——
Caspase-Glo® 3/7 Assay SystemPromega——
Caspase-Glo® 3/7 Assay System — Evidence — PubIndex